NIH-funded research Sbir 1 grant

HERMOSA: Understanding perimenopausal experiences in Latina women using Apple Watch data

Official title: HERMOSA: Understanding the Perimenopausal Health Experience of Latina Women Using Digital Biomarkers from Apple Watch.

Funded at Amissa, INC. · NIH-11349550 · Data updated 2026-11-12

Aimed at Latina women going through perimenopause, this project uses Apple Watch data to understand hot flashes and related symptoms to improve personalized care.

Quick facts

Grant typeSbir 1 grant
Study typeNIH-funded research
Funding institutionAmissa, INC.
NIH-funded
Lab location1 site (Charlotte, UNITED STATES)
Project startAugust 17, 2026
Project endJuly 30, 2027
Funding year2026
Award (this year)$504,222
NIH project number1R43MD021449-01
Project IDNIH-11349550 on NIH RePORTER

Who could benefit from this research

Could help

Latina women in perimenopause experiencing vasomotor symptoms who are willing to use a smartwatch-based monitoring app.

Less likely to help

Women not experiencing notable perimenopausal symptoms or who do not use wearable devices may not benefit from this approach.

What this research studies

This Phase I SBIR project develops digital biomarkers to detect and monitor vasomotor symptoms in perimenopausal Latina women by collecting physiological data from Apple Watch sensors. The study leverages Amissa Health’s platform to gather continuous data (skin temperature, heart rate, movement, sleep) alongside self-reported symptoms through a mobile app. By analyzing high-frequency real-world data, the project seeks to create scalable tools that could lead to better, more accessible management of menopause-related symptoms, even in remote or underserved communities. Recruitment will target a cohort of Latina women experiencing perimenopausal symptoms to establish preliminary biomarker signals and data-driven insights.

Why it matters

Potential benefit: If successful, the tools could enable earlier detection and personalized management of perimenopause symptoms for Latinas, potentially improving sleep, mood, and quality of life.

How similar studies have gone: This area is growing but remains emerging; prior work supports feasibility of digital biomarkers for symptom monitoring in other populations, with limited representation in Latina perimenopause.

Where this research is happening

  • Amissa, INC.
    Charlotte, United States
    Active

Researchers

  • Principal investigator: Corkey, Jon Andrew — Amissa, INC.
  • Study coordinator: Corkey, Jon Andrew

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.